Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Davis

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2019
Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary groupHester Lieng, Andrew Kneebone, Amy J Hayden, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2024
Five-Year Outcomes of Moderately Hypofractionated Proton Therapy Incorporating Elective Pelvic Nodal Irradiation for High-Risk Prostate CancerRichard Choo, David W Hillman, Cecilia Mitchell, et al.
Brachytherapy|January 24, 2012
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapyBrian J Davis, Eric M Horwitz, W Robert Lee, et al.
Cancer Research|October 4, 2015
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing RadiationDaniel E Spratt, Michael J Evans, Brian J Davis, et al.
The Prostate|October 30, 2023
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasisAhmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2018
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary groupHester Lieng, Amy J Hayden, David R H Christie, et al.
Journal of the American College of Radiology : JACR|March 28, 2022
The ABR 2021 Radiation Oncology Remote Examinations: Development, Administration, and Implications for the FuturePaul E Wallner, Anthony M Gerdeman, Lydia Warg, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2021
A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer PatientsNeha Vapiwala, J Karen Wong, Elizabeth Handorf, et al.
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
Neuropharmacology|November 24, 2019
c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific mannerAngela N Henderson-Redmond, Caitlin M Nealon, Brian J Davis, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2019
Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary groupHester Lieng, Andrew Kneebone, Amy J Hayden, et al.
International Journal of Radiation Oncology, Biology, Physics|December 13, 2024
Five-Year Outcomes of Moderately Hypofractionated Proton Therapy Incorporating Elective Pelvic Nodal Irradiation for High-Risk Prostate CancerRichard Choo, David W Hillman, Cecilia Mitchell, et al.
Brachytherapy|January 24, 2012
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapyBrian J Davis, Eric M Horwitz, W Robert Lee, et al.
Cancer Research|October 4, 2015
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing RadiationDaniel E Spratt, Michael J Evans, Brian J Davis, et al.
The Prostate|October 30, 2023
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasisAhmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2018
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary groupHester Lieng, Amy J Hayden, David R H Christie, et al.
Journal of the American College of Radiology : JACR|March 28, 2022
The ABR 2021 Radiation Oncology Remote Examinations: Development, Administration, and Implications for the FuturePaul E Wallner, Anthony M Gerdeman, Lydia Warg, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2021
A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer PatientsNeha Vapiwala, J Karen Wong, Elizabeth Handorf, et al.
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
Neuropharmacology|November 24, 2019
c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific mannerAngela N Henderson-Redmond, Caitlin M Nealon, Brian J Davis, et al.
Pageof 15